NCT00809822View on ClinicalTrials.gov

Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Bullous Pemphigoid
Interventions
DRUG

NPB-01

Intravenous immunoglobulin

DRUG

Placebo

Physiological saline

Trial Locations (1)

Unknown

Osaka

Sponsors
All Listed Sponsors
lead

Nihon Pharmaceutical Co., Ltd

INDUSTRY